- Home
- HKIT vs IXHL Comparison
HKIT vs IXHL Comparison
Compare HKIT & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- IXHL
- Stock Information
- Founded
- HKIT 1996
- IXHL 2001
- Country
- HKIT China
- IXHL Australia
- Employees
- HKIT N/A
- IXHL N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- IXHL
- Sector
- HKIT Technology
- IXHL
- Exchange
- HKIT Nasdaq
- IXHL Nasdaq
- Market Cap
- HKIT 45.4M
- IXHL 39.2M
- IPO Year
- HKIT 2023
- IXHL N/A
- Fundamental
- Price
- HKIT $1.41
- IXHL $1.93
- Analyst Decision
- HKIT
- IXHL
- Analyst Count
- HKIT 0
- IXHL 0
- Target Price
- HKIT N/A
- IXHL N/A
- AVG Volume (30 Days)
- HKIT 54.7K
- IXHL 24.2K
- Earning Date
- HKIT 10-28-2024
- IXHL 11-14-2024
- Dividend Yield
- HKIT N/A
- IXHL N/A
- EPS Growth
- HKIT N/A
- IXHL N/A
- EPS
- HKIT 0.04
- IXHL N/A
- Revenue
- HKIT $3,449,206.00
- IXHL $86,000.00
- Revenue This Year
- HKIT N/A
- IXHL $3,817.06
- Revenue Next Year
- HKIT N/A
- IXHL $66.67
- P/E Ratio
- HKIT $37.08
- IXHL N/A
- Revenue Growth
- HKIT N/A
- IXHL N/A
- 52 Week Low
- HKIT $0.54
- IXHL $1.50
- 52 Week High
- HKIT $6.48
- IXHL $8.47
- Technical
- Relative Strength Index (RSI)
- HKIT 51.77
- IXHL 52.16
- Support Level
- HKIT $1.30
- IXHL $1.71
- Resistance Level
- HKIT $1.49
- IXHL $2.19
- Average True Range (ATR)
- HKIT 0.15
- IXHL 0.16
- MACD
- HKIT 0.00
- IXHL -0.00
- Stochastic Oscillator
- HKIT 35.14
- IXHL 41.12
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.